600535:SHA
Tasly Pharmaceutical Group Co Ltd
CN¥14,09
arrow_upward
+0,36%(+0,050) 1D
15 ຕ.ລ., 15 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT+8 · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 600535...
Open
CN¥14,04
High
CN¥14,31
Low
CN¥13,93
Mkt. cap
20,87 ຕື້
Avg. vol.
11,39 ລ້ານ
Volume
15,41 ລ້ານ
Dividend
2,41%
Quarterly dividend
CN¥0,09
Ex-dividend date
29 ພ.ພ. 2026
P/E ratio
17,21
52-wk high
CN¥16,24
52-wk low
CN¥12,90
EPS
CN¥0,82
Shares outstanding
1,51 ຕື້
No. of employees
11 ພັນ
Open
CN¥14,04
High
CN¥14,31
Low
CN¥13,93
Mkt. cap
20,87 ຕື້
Avg. vol.
11,39 ລ້ານ
Volume
15,41 ລ້ານ
Dividend
2,41%
Quarterly dividend
CN¥0,09
Ex-dividend date
29 ພ.ພ. 2026
P/E ratio
17,21
52-wk high
CN¥16,24
52-wk low
CN¥12,90
EPS
CN¥0,82
Shares outstanding
1,51 ຕື້
No. of employees
11 ພັນ
Related stocks
News stories
From web sources and news partners
CNN
·
1 ຊົ່ວໂມງກ່ອນ
Global tech selloff deepens as enthusiasm for AI stocks wobbles
The Motley Fool
·
7 ນາທີກ່ອນ
The S&P 500 Is Expecting Something Extraordinary. History Says Investors Should Be Careful What They Wish For.
Simply Wall Street
·
10 ນາທີກ່ອນ
Is SAB Biotherapeutics (NASDAQ:SABS) In A Good Position To Invest In Growth?
Profile
Tasly is a Chinese pharmaceutical company based in the city of Tianjin. It was established in 1994 and is notably producing traditional Chinese medicines.
It has a turnover of 4 billion US dollars, 10,000 employees and is listed on the Shanghai Stock Exchange.
In 2009, Chinese pharmacologist Li Lianda claimed that a key product made by Tasly was unsafe. Tasly sued Li in 2013, alleging that Li's claim was baseless and was motivated by his financial and employment relations with Guangzhou Pharmaceutical, a direct competitor of Tasly. In September 2014, the Tianjin High People's Court ruled in favour of Tasly and ordered Li to issue an apology and pay Tasly 300,000 yuan in compensation.
In February 2017, Tasly announced plans to form a joint venture with American multi-level marketing company Herbalife. Wikipedia
About Tasly Pharmaceutical Group Co Ltd